title: A reality check: the cost of making post-exposure prophylaxis available to gay and bisexual men at high sexual risk.
authors.forename: S
authors.initials: S
authors.lastname: Low-Beer
authors.forename: A E
authors.initials: AE
authors.lastname: Weber
authors.forename: K
authors.initials: K
authors.lastname: Bartholomew
authors.forename: M
authors.initials: M
authors.lastname: Landolt
authors.forename: D
authors.initials: D
authors.lastname: Oram
authors.forename: J S
authors.initials: JS
authors.lastname: Montaner
authors.forename: M V
authors.initials: MV
authors.lastname: O'Shaughnessy
authors.forename: R S
authors.initials: RS
authors.lastname: Hogg
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D001727:Bisexuality; D001955:British Columbia / Q000453:epidemiology; D016527:Drug Costs; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control*; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D012307:Risk Factors; D012747:Sexual Partners
chemical_list: D019380:Anti-HIV Agents